Stockreport

Cabaletta Bio to Present at the Evercore ISI 2nd Annual HealthCONx Conference

Cabaletta Bio, Inc.  (CABA) 
PDF PHILADELPHIA, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of [Read more]